Skip to Main

2024 M&A and Strategic Collaborations

  • Oppenheimer & Co. Inc.
  • January 1, 2025
Downloads for these reports have been deactivated.

Please contact Daniel at Daniel.Parisotto@opco.com to request a copy.
biomea fusion deal
Michael Margolis
Name:

Michael A. Margolis, R.Ph.

Title:

Senior Managing Director, Head of Healthcare Investment Banking

Daniel Parisotto, PhD
Name:

Daniel Parisotto, PhD

Title:

Managing Director, Healthcare Investment Banking

DISCLOSURES

This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.

This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.

2025 Oppenheimer & Co. Inc. Transacts Business on all Principal Exchanges and Member SIPC 7498012.1